ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/AXL-inhibitor

Search results

target/AXL-inhibitor
10 trial(s) found.
NCT07293351
NCT07227402
NCT06120075
NCT05691478
2031 - Randwick - Sydney Children's Hospital (SUSPENDED)
NCT05536141
NCT05327686
NCT04293562
NCT03409081
ACTRN12624000082505
ACTRN12616001187437
Filters
AXL
100%
KIT
60%
MET
60%
RET
60%
ROS1
60%
VEGFR
60%
VEGFR2
60%
FLT3
40%
PD-1
30%
PD-1/PD-L1
30%
CTLA4
20%
PD-L1
20%
HIF2a
20%
PDGFR
20%
VEGFA
10%
MER
10%
VEGF
10%
CD33
10%
Bcl2
10%
ALK
10%
BCR-ABL1
10%
CDK4
10%
CDK6
10%
CRAF
10%
EGFR
10%
ERBB2
10%
FGFR1
10%
FGFR1/2/3
10%
FGFR2
10%
FGFR3
10%
FGFR4
10%
HDAC
10%
IGF1R
10%
MEK
10%
PARP
10%
PDGFRA
10%
RAF
10%
SRC
10%
YES1
10%
mTOR
10%
mTORC1
10%
proteasome
10%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.